Mood and anxiety disorders in patients with multiple sclerosis

References

• Amato MP, Ponziani G, Rossi F, Liedl CL, Stefanile C, Rossi L. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001; 7: 340–4
   PubMed Web of Science ®Google Scholar
• Janssens ACJW, van Doorn PA, de Boer JB, van der Meché FGA, Passchier J, Hintzen RQ. Impact of recently diagnosed multiple sclerosis on quality of life, anxiety, depression and distress of patients and partners. Acta Neurol Scand 2003; 108: 389–95
   PubMed Web of Science ®Google Scholar
• Miller A, Dishon S. Health-related quality of life in multiple sclerosis: The impact of disability, gender and employment status. Qual Life Res 2006; 15: 259–71
   PubMed Web of Science ®Google Scholar
• Figved N, Klevan G, Myhr KM, et al. Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatr Scand 2005; 112: 463–8
   PubMed Web of Science ®Google Scholar
• Kaya N, Akpınar Z, Çilli AS. Relationship between depression and anxiety and quality of life in multiple sclerosis. Anatolian J Psychiatry 2003;4:220–5 ( Turkish).
   Google Scholar
• Galeazzi GM, Ferrari S, Giaroli G, et al. Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy. Neurol Sci 2005; 26: 255–62
   PubMed Web of Science ®Google Scholar
• Ron MA, Logsdail SJ. Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med 1989; 19: 887–95
   PubMed Web of Science ®Google Scholar
• Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 2005; 76: 469–75
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology 1996; 46: 628–32
   PubMed Web of Science ®Google Scholar
• Minden SL, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987; 9: 426–34
   PubMed Web of Science ®Google Scholar
• Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol 1990; 47: 98–104
   PubMed Web of Science ®Google Scholar
• Janardhan V, Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002; 205: 51–8
   PubMed Web of Science ®Google Scholar
• Lobentanz IS, Asenbaum S, Vass K, et al. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality. Acta Neurol Scand 2004; 110: 6–13
   PubMed Web of Science ®Google Scholar
• Möller A, Wiedemann G, Rohde U, Backmund H, Sonntag A. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis. Acta Psychiatr Scand 1994; 89: 117–21
   PubMed Web of Science ®Google Scholar
• Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft KH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiologic study of a large community sample. Am J Psychiatry 2002; 159: 1862–8
   PubMed Web of Science ®Google Scholar
• Patten SB, Beck CA, Williams JWA, Barbui C, Metz LM. Major depression in multiple sclerosis. A population-based perpective. Neurology 2003; 61: 1524–7
   PubMed Web of Science ®Google Scholar
• Patten SB, Lavorato DH, Metz LM. Clinical correlates of CES-D depressive symptom ratings in an MS population. Gen Hosp Psychiatry 2005; 27: 439–45
   PubMed Web of Science ®Google Scholar
• Chwastiak LA, Gibbons LE, Ehde DM, et al. Fatigue and psychiatric illness in a large community sample of persons with multiple sclerosis. J Psychosom Res 2005; 59: 291–8
   PubMed Web of Science ®Google Scholar
• Williams RM, Turner AP, Hatzakis M, Bowen JD, Rodriquez AA, Haselkorn JK. Prevalence and correlates of depression among veterans with multiple sclerosis. Neurology 2005; 64: 75–80
   PubMed Web of Science ®Google Scholar
• Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–31
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical ınterview for DSM-IV. Clinical version (SCID-I/CV). American Psychiatric Press, Washington, DC 1997
   Google Scholar
• Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444–52
   PubMed Web of Science ®Google Scholar
• Regier DA, Farmer ME, Rae DS, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment area Study. Acta Psychiatr Scand 1993; 88: 35–47
   PubMed Web of Science ®Google Scholar
• Vicente B, Kohn R, Rioseco P, Saldivia S, Baker C, Torres S. Population prevalence of psychiatric disorders in Chile: 6-month and 1-month rates. Br J Psychiatry 2004; 84: 299–305
   Web of Science ®Google Scholar
• Wittchen HU, Essau CA, von Zerssen D, Krieg JC, Zaudig M. Lifetime and six-month prevalence of mental disorders in the Munich follow-up study. Eur Arch Psychiatry Clin Neurosci 1992; 241: 247–58
   PubMed Web of Science ®Google Scholar
• Canino GJ, Bird HR, Shrout PE, et al. The prevalence of spesific psychiatric disorders in Puerto Rico. Arch Gen Psychiatry 1987; 44: 727–35
   PubMed Web of Science ®Google Scholar
• Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of spesific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949–58
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Jin R, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593–602
   PubMed Web of Science ®Google Scholar
• Smith SJ, Young CA. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil 2000; 14: 50–4
   PubMed Web of Science ®Google Scholar
• Wilhelm K, Mitchell P, Slade T, Brownhill S, Andrews G. Prevalence and correlates of DSM-IV major depression in an Australian national survey. J Affect Disord 2003; 75: 155–62
   PubMed Web of Science ®Google Scholar
• Ohayon MM, Priest RG, Guilleminault C, Caulet M. The prevalence of depressive disorders in the United Kingdom. Biol Psychiatry 1999; 45: 300–7
   PubMed Web of Science ®Google Scholar
• Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a National Community Sample: The National Comorbidity Survey. Am J Psychiatry 1994; 51: 979–86
   Google Scholar
• Feinstein A, Feinstein K. Depression associated with multiple sclerosis. Looking beyond diagnosis to symptom expression. J Affect Disord 2001; 66: 193–8
   PubMed Web of Science ®Google Scholar
• Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Mood disorder and multiple sclerosis. Arch Neurol 1987; 44: 376–8
   PubMed Web of Science ®Google Scholar
• Faravelli C, Degl'Innocenti BG, Giardinelli L. Epidemiology of anxiety disorders in Florence. Acta Psychiatr Scand 1989; 79: 308–12
   PubMed Web of Science ®Google Scholar
• Dalos NP, Rabins PV, Brooks BR, O'Donnell P. Disease activity and emotional state in multiple sclerosis. Ann Neurol 1983; 13: 573–7
   PubMed Web of Science ®Google Scholar
• McCabe MP. Mood and self-esteem of persons with multiple sclerosis following an exacerbation. J Psychosom Res 2005; 59: 161–6
   PubMed Web of Science ®Google Scholar
• Zorzon M, Zivadinov R, Nasuelli D, et al. Depressive symptoms and MRI changes in multiple sclerosis. Eur J Neurol 2002; 9: 491–6
   PubMed Web of Science ®Google Scholar
• Feinstein A, Roy P, Lobaugh N, Feinstein K, O'Connor P, Black S. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62: 586–90
   PubMed Web of Science ®Google Scholar
• Derache N, Marié RM, Constans JM, Defer GL. Reduced thalamic and cerebellar rest metabolism in relapsing–remitting multiple sclerosis, a positron emission tomography study: Correlations to lesion load. J Neurol Sci 2006; 245: 103–9
   PubMed Web of Science ®Google Scholar
• Tsukada N, Miyagi K, Matsuda M, Yanagisawa N, Yone K. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 1991; 104: 230–4
   PubMed Web of Science ®Google Scholar
• Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M. Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 2001; 11: 203–8
   PubMed Web of Science ®Google Scholar
• Caggiula M, Batocchi AP, Frisullo G, et al. Neurotrophic factors and clinical recovery in relapsing–remitting multiple sclerosis. Scand J Immunol 2005; 62: 176–82
   PubMed Web of Science ®Google Scholar
• Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H. Synergistic effects of interleukin-1 β, interleukin-6, and tumor necrosis factor-α: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 2000; 22: 566–80
   PubMed Web of Science ®Google Scholar